Finnovate Acquisition Corp
Finnovate Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on the acquisition of Israel-related companies, including companies focused on payments, insuretech, wealt… Read more
Finnovate Acquisition Corp (FNVT) - Net Assets
Latest net assets as of September 2024: $21.59 Million USD
Based on the latest financial reports, Finnovate Acquisition Corp (FNVT) has net assets worth $21.59 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($26.17 Million) and total liabilities ($4.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $21.59 Million |
| % of Total Assets | 82.49% |
| Annual Growth Rate | -47.72% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 36.72 |
Finnovate Acquisition Corp - Net Assets Trend (2021–2023)
This chart illustrates how Finnovate Acquisition Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Finnovate Acquisition Corp (2021–2023)
The table below shows the annual net assets of Finnovate Acquisition Corp from 2021 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $48.40 Million | -72.82% |
| 2022-12-31 | $178.08 Million | +0.63% |
| 2021-12-31 | $176.97 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Finnovate Acquisition Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 215778200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $51.20 Million | 105.78% |
| Total Equity | $48.40 Million | 100.00% |
Finnovate Acquisition Corp Competitors by Market Cap
The table below lists competitors of Finnovate Acquisition Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Natural Beauty Bio-Technology Limited
PINK:NBBTF
|
$29.03 Million |
|
Rimbunan Sawit Bhd
KLSE:5113
|
$29.04 Million |
|
Chungdamglobal Co. Ltd.
KQ:362320
|
$29.04 Million |
|
Arcario AB
ST:ARCA
|
$29.05 Million |
|
Hi Sharp Electronics Co Ltd
TWO:3128
|
$29.03 Million |
|
Ssangyong Information & Communications Corp
KQ:010280
|
$29.02 Million |
|
Long Time Technology Co., Ltd.
TWO:6555
|
$29.02 Million |
|
Daxor Corporation
NASDAQ:DXR
|
$29.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Finnovate Acquisition Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 178,075,710 to 48,403,462, a change of -129,672,248 (-72.8%).
- Net income of 2,494,909 contributed positively to equity growth.
- Share repurchases of 132,616,922 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.49 Million | +5.15% |
| Share Repurchases | $132.62 Million | -273.98% |
| Other Changes | $449.76K | +0.93% |
| Total Change | $- | -72.82% |
Book Value vs Market Value Analysis
This analysis compares Finnovate Acquisition Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.23x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.42x to 3.23x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $8.21 | $11.62 | x |
| 2022-12-31 | $8.20 | $11.62 | x |
| 2023-12-31 | $3.60 | $11.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Finnovate Acquisition Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.15%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.06x
- Recent ROE (5.15%) is above the historical average (2.29%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -0.36% | 0.00% | 0.00x | 1.00x | $-18.34 Million |
| 2022 | 2.07% | 0.00% | 0.00x | 1.01x | $-14.11 Million |
| 2023 | 5.15% | 0.00% | 0.00x | 1.06x | $-2.35 Million |
Industry Comparison
This section compares Finnovate Acquisition Corp's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Finnovate Acquisition Corp (FNVT) | $21.59 Million | -0.36% | 0.21x | $29.03 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |